HugoScore hugoscore.org

Ambient scribe

Abridge

Abridge is clinician-controlled documentation and decision support. UChicago Medicine documents patient refusal and note-correction routes, but these local commitments cannot describe every customer. Platform expansion does not establish that all patient recordings feed every offering.

Document-based draft Read full report Open directory

Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.

Constrains0 of 12 agency checks metDocument-based draft. Independent confirmation incomplete; not product-tested.How categories work

Agency checklist · October 30, 2026

Constrains 0 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: Ambient AI scribe used by clinicians/health systems: records the patient-clinician conversation and drafts the clinical note

Astra review conflicted: OpenAI model in role record.

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AINodeployer-dependent
Not independently replicated
Your clinician will always ask for your consent first. Source

This is UChicago Medicine's own policy for its deployment. No Abridge document says a consent or AI notice is always given. Abridge's privacy policy sends patients to their provider's Notice of Privacy Practices.

2. Operator and model maker namedNonot-documented
Not independently replicated
leveraging the strongest capabilities of foundation models, like GPT-5.5, to power other features Source

Abridge AI Inc. is named, and the health system is named in deployments such as UChicago. The model maker is not clearly named for the scribe. This April 2026 blog says Abridge tested OpenAI's GPT-5.5 for note generation and decision support, and mixes in its own proprietary-data models. It does not say which model produces patients' notes. Closest call in this set.

3. Patient chooses to use itNodocumented
Not independently replicated
process your data solely on their instruction Source

The privacy policy says Abridge is a Business Associate to the provider and acts on the provider's instruction. UChicago's article says the health system rolled it out for clinicians. The patient does not start it.

4. Patient sets the taskNodocumented
Not independently replicated
record the conversation between you and your clinician and transform it into a clear, accurate clinical note for your EHR Source

The purpose (documentation for the clinician and health system) is fixed by the operator. The patient does not set it.

5. Patient can decline or stopNodeployer-dependent
Not independently replicated
If you decline, your visit will proceed just as before, with no change in your care. Source

This is UChicago's policy. No Abridge document guarantees a right to decline in every deployment. The Abridge patient terms say use is voluntary, but they cover the retired consumer app, not the clinician scribe.

6. Patient sees the AI outputNonot-documented
Not independently replicated
Our software allows clinicians to validate each part of a generated note against the underlying patient conversation transcript and audio recording. Source

Sources describe the clinician seeing the AI draft, transcript and audio. UChicago says patients can read the final clinician-approved note through open notes, which is a person-reviewed product. No source says patients see the AI's own draft or transcript.

7. Patient can correct or challengeNodeployer-dependent
Not independently replicated
the right to access, correct, amend or delete such information, please inquire with the relevant Abridge customer directly Source

The route runs through the health system, and the policy wording is conditional ("as applicable"). UChicago says patients can message the clinician to fix errors in the note. That is the institution's route, not a vendor route, and it applies to the final note, not the AI draft.

8. Patient can get a copyNodeployer-dependent
Not independently replicated
the right to access, correct, amend or delete such information, please inquire with the relevant Abridge customer directly Source

Access is only via the health system. The patient page offered recording export for the consumer app, but that app closed Aug 18, 2025, and the export request deadline of Dec 31, 2025 has passed (https://www.abridge.com/patients). That page does not apply to the clinician scribe.

9. Patient can deleteNodeployer-dependent
Not independently replicated
Audio recordings made by the tool are used solely to produce the clinical notes before being deleted Source

This is UChicago's retention practice. The patient does not trigger it. Abridge's own policy sends deletion requests to the health system. The consumer-app deletion route (support email) closed Dec 31, 2025.

10. Training or sale does not override patient choiceNodeployer-dependent
Not independently replicated
governed exclusively by the terms of our agreements with those customers Source

Patient data use is set by private customer contracts that are not public, and no patient-level opt-out is documented. UChicago says "no secondary data use," but that is a deployer statement. The Abridge blog says it trains models on proprietary data, without saying what data. The old consumer terms gave Abridge rights over de-identified derivatives, but they apply to the retired app.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Abridge processes Customer Data, which may include Protected Health Information (PHI), solely on behalf of our customers. Source

Clinician-facing and vendor-hosted. The patient is not a user. The policy points patients to their provider for access, correction and deletion. No self-hosting, no open source, no patient path to take the function elsewhere.

12. No advertising or data businessNodeployer-dependent
Not independently replicated
Abridge processes Customer Data, which may include Protected Health Information (PHI), solely on behalf of our customers. Source

The policy says use of Customer Data is governed exclusively by Abridge's agreements with each health system. Those agreements are not public, so nothing says the same terms apply to every deployment. Separately, the policy documents that Abridge shared identifiers and device activity with advertising partners for cross-context behavioral advertising. That concerns website and account users, not patient visit data.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier v1.3 assessment and control finding

Historical assessment under different rules. It does not set the current checklist zone.

MixedEarlier review, before the published method. Documents only.

Agency finding, before method v1.3

Mixed

Control axis not applicable: clinician-operated

Historical editorial placement, pre-method: 43. No longer shown on the control axis.

This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.

Evidence
Documentary review. Public sources only, no hands-on testing by HugoScore.
Review status
AI draft. No person has settled the findings.
The question we ask Who does Abridge serve in this deployment?
Control Ambient AI scribe used by clinicians/health systems: records the patient-clinician conversation and drafts the clinical note
Agency read Constrains
Vendor
Abridge AI, Inc.
Who it serves
Institutional, clinician-mediated
Primary User
Clinicians and health systems; vendor also markets payer and life-sciences integrations
Control Model
Professional or institution-configured service. Patient controls depend on the deployment.
Patient Impact
Open notes can support patient checking. Clinician-facing citations do not establish patient access to the same reasoning, recordings or source interface.
Profile Status
Document-based draft
Last assessed
Oct 30, 2026
Earlier review confidence
Moderate for public deployment policy and CDS design (AI-assisted draft)
Earlier review model
OpenAI Codex / GPT-6
Earlier human review record
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Earlier evidence and assessment

The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.

Earlier finding · Control axis not applicable: clinician-operated

Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 43. Not comparable with v1.3 positions.

Mixed

Abridge is clinician-controlled documentation and decision support. UChicago Medicine documents patient refusal and note-correction routes, but these local commitments cannot describe every customer. Platform expansion does not establish that all patient recordings feed every offering.

Patient agency

How this tool changes agency

Expands agency when

Open notes can support patient checking. Clinician-facing citations do not establish patient access to the same reasoning, recordings or source interface.

Limits agency when

Actual consent practice and downstream use across customers, and current litigation status, were not established

Patient agency assessment

Who sets and changes the goal?

Patient authority

Clinical users decide what enters the record and what action follows. UChicago documents a real patient refusal and correction route, with no claim that the patient controls the assistant itself.

What can the patient understand, question, or do?

Critical capacity

Open notes can support patient checking. Clinician-facing citations do not establish patient access to the same reasoning, recordings or source interface.

Can the patient evaluate the conditions of use?

Informed control

Consent and retention must be described by deployment. Vendor expansion into payer and life-sciences workflows does not prove that the same patient audio feeds every offering.

Text findings

Conditions of use

Published controls and their limits

Consent and retention must be described by deployment. Vendor expansion into payer and life-sciences workflows does not prove that the same patient audio feeds every offering.

What remains unknown?

Not tested or not established

Actual consent practice and downstream use across customers, and current litigation status, were not established

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Earlier review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Actual consent practice and downstream use across customers, and current litigation status, were not established No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Earlier review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

Document-based draft · Moderate for public deployment policy and CDS design (AI-assisted draft)